Studying heart disease with leaky mitral valve in China
Part of Heart & circulation clinical trials.
This study looks at people with coronary heart disease who also have a leaky mitral valve caused by heart muscle damage. It aims to understand the condition better and may help improve treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with coronary heart disease (blockages in heart arteries)
- Your leaky mitral valve was found during a regular clinic visit or hospital stay
- An ultrasound showed your mitral valve leak is moderate or severe and is due to heart muscle damage
- You have not had any heart valve surgery or been in another clinical study in the past year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies an “epicardial” device placed during planned heart surgery to reduce mitral valve leaking (“mitral regurgitation”). If you have moderate-to-severe valve leak from ischemic heart disease and are already scheduled for heart surgery, this may help improve how well the valve works.
This study looks at how symptoms relate to the severity of mitral regurgitation, a leaky heart valve. Researchers want to better understand the link between what you feel and the actual degree of the leak.
This trial tests a new device designed to fix a leaky mitral valve in people with heart failure. It may help you breathe easier and feel less tired if your valve leak is severe and medicines have not been enough.
This trial focuses on people with severe mitral valve narrowing or leaking who still have symptoms even after the best usual medications. It may help find better care and measure health outcomes when surgery is judged too risky or not suitable.
This trial compares two treatment approaches for people with heart failure and a leaky mitral valve (mitral regurgitation). It aims to find which strategy leads to better outcomes. You may be eligible if your heart function is reduced and you have symptoms despite standard treatments.
This trial tests a treatment for people with atrial fibrillation who also have a leaky mitral valve. It aims to see if treating both conditions together can improve symptoms.
Hear when a new Ischemic Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.